Common Contracts
19 similar Equity Distribution Agreement contracts by Atossa Therapeutics, Inc., ExOne Co, Akerna Corp., others
ICOSAVAX, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 16th, 2022 • Icosavax, Inc. • Biological products, (no disgnostic substances) • New York
Icosavax, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
ATOMERA INCORPORATED $50,000,000 COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • May 31st, 2022 • Atomera Inc • Semiconductors & related devices • New York
Atomera Incorporated, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc. and Craig-Hallum Capital Group LLC, as follows:
KAZIA THERAPEUTICS LIMITED AMERICAN DEPOSITARY SHARES REPRESENTING ORDINARY SHARES EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • April 22nd, 2022 • Kazia Therapeutics LTD • Pharmaceutical preparations • New York
Kazia Therapeutics Limited ACN 063 259 754, an Australian public company limited by shares (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
ONDAS HOLDINGS INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • March 22nd, 2022 • Ondas Holdings Inc. • Radio & tv broadcasting & communications equipment • New York
Ondas Holdings Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
FREQUENCY THERAPEUTICS, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 10th, 2021 • Frequency Therapeutics, Inc. • Pharmaceutical preparations • New York
Frequency Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
STRATA SKIN SCIENCES, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • October 18th, 2021 • STRATA Skin Sciences, Inc. • Surgical & medical instruments & apparatus • New York
STRATA Skin Sciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Ladenburg Thalmann & Co. Inc., as follows:
PROCESSA PHARMACEUTICALS, Inc. $30 Million OF COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 20th, 2021 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
CYCLO THERAPEUTICS, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 16th, 2021 • Cyclo Therapeutics, Inc. • Industrial organic chemicals • New York
Cyclo Therapeutics, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
AKERNA CORP. $25,000,000 COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • July 23rd, 2021 • Akerna Corp. • Services-computer processing & data preparation • New York
Akerna Corp., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
REZOLUTE, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 18th, 2020 • Rezolute, Inc. • Pharmaceutical preparations • New York
Rezolute, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
ATOSSA THERAPEUTICS, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • September 25th, 2020 • Atossa Therapeutics, Inc. • Pharmaceutical preparations • New York
Atossa Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Maxim Group LLC, as follows:
THE EXONE COMPANY COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • September 11th, 2020 • ExOne Co • Printing trades machinery & equipment • New York
The ExOne Company, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Canaccord Genuity LLC, as follows:
COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • August 11th, 2020 • Cellectar Biosciences, Inc. • Pharmaceutical preparations • New York
Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
THE EXONE COMPANY COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • June 11th, 2020 • ExOne Co • Printing trades machinery & equipment • New York
The ExOne Company, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
ISORAY, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • April 6th, 2020 • Isoray, Inc. • Surgical & medical instruments & apparatus • New York
Isoray, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
ATOSSA THERAPEUTICS, INC. COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • February 10th, 2020 • Atossa Therapeutics, Inc. • Pharmaceutical preparations • New York
Atossa Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • September 20th, 2019 • Interpace Diagnostics Group, Inc. • Surgical & medical instruments & apparatus • New York
Interpace Diagnostics Group, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
VASCULAR BIOGENICS LTD. ORDINARY SHARES EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • May 17th, 2019 • Vascular Biogenics Ltd. • Pharmaceutical preparations • New York
Vascular Biogenics Ltd., a company organized under the laws of the State of Israel (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
VOLITIONRX LIMITED COMMON STOCK EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • September 10th, 2018 • Volitionrx LTD • In vitro & in vivo diagnostic substances
VolitionRx Limited, a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Oppenheimer & Co. Inc., as follows:
